ClinicalTrials.gg
CompletedNCT03285464Updated Feb 26, 2018

Utilizing the Trunk as a Proximal Lever to Strengthen the Hip Musculature and Alter Lower Extremity Function

An interventional study of Triplanar Rotary Resistance in Patellofemoral Pain Syndrome, sponsored by High Point University. Completed at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-02-26.

Sponsored by High Point University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Does a rotary based triplanar exercise intervention that utilizes the trunk as a proximal lever, strengthen the hip and alter dynamic LE alignment in running females?

Read the detailed description

Current hip-focused programs fail to alter hip adduction angles in females while performing higher speed and more complex maneuvers such as running.

(Willy, et al., 2011) - 10 female runners, underwent 6 wk. hip focused intervention, change in SLS but NO change in hip adduction angle while running.

A different intervention strategy that includes utilizing the trunk as the proximal lever to strengthen the hip, could potentially alter biomechanical outcomes such as hip adduction angles in female runners.

This study will apply a new intervention model and then measure running, single leg squat and hip strength to determine if a newly informed intervention can alter LE kinematics in females while running and make improvements in hip strength following the intervention Inclusion Criteria

  • 18 years old or greater
  • Female Exclusion Criteria
  • Injury of the lumbar spine, hips, knees or foot/ankle in the last 6mos that required medical attention
  • any surgery of the lower back or the pelvis or lower extremities any time in the subjects life
02

Conditions studied

  • Patellofemoral Pain Syndrome

Keywords

  • knee
  • hip
  • exercise
  • proximal control
  • PFPS
03

In context

Patellofemoral Pain Syndrome

299 studies on the registry are indexed under Patellofemoral Pain Syndrome; 74 are open to participants now.

This study's enrollment of 32 is below the median of 46 across 246 interventional studies indexed under Patellofemoral Pain Syndrome.

Browse Patellofemoral Pain Syndrome studies →

Lead sponsor

High Point University is the lead sponsor of 14 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18> year old female; must be able to run on the treadmill for 5-7 min and perform a single leg squat

Exclusion criteria

Exclusion Criteria:

  • surgery to the LB or lower extremities Significant injury (seeking medical attention) to the LB or LEs in the last 6mos.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
32 participants (actual)

Study arms

  • Active comparator
    Hip

    This group will perform a known hip strengthening program

    Other: Triplanar Rotary Resistance

  • Experimental
    Trunk

    This group will use the trunk as a lever to strengthen the hip

    Other: Triplanar Rotary Resistance

Interventions

  • OtherTriplanar Rotary Resistance

    Trunk group will strengthen the hip using the trunk as a lever to access the hip. The hip group will use femur as the lever to strengthen the hip.

    Also known as: Convention Hip Focused

06

What researchers measure

Primary outcomes

  1. Change in Hip Strength after a 12 week hip focused intervention

    Isometric hand held dynamometer

    Time frame: Baseline measures at initial data collection; repeat post intervention measures at 6wks

Secondary outcomes

  1. Biomechanical assessment of single leg squat

    Subject squats on single leg and qualitative scoring is administered to determine the subjective amount of contralateral pelvic drop and femoral adduction to be described as dynamic knee valgus. The qualitative values will be binary in nature, whereas DKV is present or not.

    Time frame: Baseline measures at initial data collection; repeat post intervention measures at 6wks

  2. Biomechanical Running Assessment

    2/3D analysis of running gait following intervention; Utilizing both 3D/2D methods the measure of contralateral pelvic drop and the bisection of the patella will determine the amount of femoral adduction noted during running. The change in the femoral adduction angle after a 6 week intervention is the specific outcome measure to be obtained.

    Time frame: Baseline measures at initial data collection; repeat post intervention measures at 6wks

07

Study locations

1 site
  • High Point University
    High Point, North Carolina 27268, United States
08

References and documents

Individual participant data

Plan to share: Undecided — The data collected will only be shared amongst the research team named in this protocol.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2017 to primary completion in Dec 2017, 4 months.

Of 154 non-industry interventional studies with no phase under Patellofemoral Pain Syndrome, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 20. This study's 4 months is below that.

Counting every sponsor, half of 158 studies reached it within 11 months; a quarter within 4 and three quarters within 21.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 12, 2017
First posted
Sep 18, 2017
StartActual
Aug 9, 2017
Primary completionActual
Dec 15, 2017
CompletionActual
Dec 15, 2017
Last update
Feb 26, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 26, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03285464
Lead sponsor
High Point University
Responsible party
Sponsor
First posted
Sep 18, 2017
Start date
Aug 9, 2017
Primary completion
Dec 15, 2017
Completion
Dec 15, 2017
Last update
Feb 26, 2018

Study contacts

Alexis Wright, DPT
principal investigator · HPU
Eric Hegedus, DPT
study chair · HPU
Kevin Ford, PhD
study director · HPU

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion